Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker Diabetic Fatty rat)

This study was performed to assess the effect of chronic low-dose sitagliptin, a dipeptidyl peptidase 4 inhibitor, on metabolic profile and on renal lesions aggravation in a rat model of type-2 diabetic nephropathy, the Zucker Diabetic Fatty (ZDF) rat. Diabetic and obese ZDF (fa/fa) rats and their c...

Full description

Bibliographic Details
Main Author: Mega, C. (author)
Other Authors: Teixeira de Lemos, E. (author), Vala, Helena (author), Fernandes, R. (author), Oliveira, J. (author), Mascarenhas-Melo, F. (author), Teixeira, F. (author), Reis, F. (author)
Format: article
Language:eng
Published: 2013
Subjects:
type 2 diabetic nephropathy
sitagliptin
dysmetabolism
renal lesion
ZDF rat
Online Access:http://hdl.handle.net/10400.19/1413
Country:Portugal
Oai:oai:repositorio.ipv.pt:10400.19/1413

Internet

http://hdl.handle.net/10400.19/1413

Similar Items